17 results found.

Hyperlipidemia Clinical Trial using PF-04950615; Placebo

Pfizer - Recruiting 18 years or older.
- A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events.
PF-04950615; Placebo

Dyslipidemia Clinical Trial using K-877 Low Dose; Moxifloxacin 400mg; Placebo; K-877 High Dose

Kowa Research Institute, Inc. - Recruiting 18 years to 45 years.
- .
K-877 Low Dose; Moxifloxacin 400mg; Placebo; K-877 High Dose

Dyslipidemia Clinical Trial using Evolocumab (AMG 145); Placebo; Effective statin therapy

Amgen - Recruiting 40 years to 85 years.
- A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease.
Evolocumab (AMG 145); Placebo; Effective statin therapy

Hyperlipidemia and Mixed Dyslipidemia Clinical Trial using evolocumab (AMG 145) and standard of care; Standard of care

Amgen - Recruiting 18 years to 85 years.
- A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145-2.
evolocumab (AMG 145) and standard of care; Standard of care

Hyperlipidemia, Hypercholesterolemia, or Dyslipidemia Clinical Trial

Ohio State University - Recruiting 18 years or older.
- An Observational Study Investigating Genetic Influences on Statin Plasma Concentrations in Adults Taking Atorvastatin, Simvastatin, or Lovastatin.

Dyslipidemia Clinical Trial using Diet

Tufts University - Recruiting 50 years or older.
- Dietary Carbohydrate Type and CVD Risk Indicators.
Diet

Dyslipidemia Clinical Trial using Motivational Interviewing (MINT); Usual Care

University of Miami - Recruiting 35 years to 85 years.
- Improving Adherence to Cholesterol Lowering Medications Among Minority Populations in Florida: A Randomized Trial.
Motivational Interviewing (MINT); Usual Care

Dyslipidemia Clinical Trial using PRC-4016

Pronova BioPharma - Recruiting 18 years to 79 years.
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia.
PRC-4016

Menopause, Hot Flushes, Osteoporosis, or Dyslipidemia Clinical Trial using Placebo; Red Clover extract

Aarhus University Hospital - Recruiting 45 years to 65 years.
- Alternative Treatments for Menopausal Women: The Efficacy of a Novel Red Clover Treatment on Menopausal Women..
Placebo; Red Clover extract

Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascu Clinical Trial using Statin; Placebo; Study Drug

Amgen - Recruiting 20 years to 85 years.
- A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG145) on LDL-C in Combination With Statin Therapy in Japanese Subjects With High Cardiovascular Risk and With Hyperlipidemia or Mixed Dyslipidemia.
Statin; Placebo; Study Drug

Psoriasis, Cardiovascular Diseases, or Dyslipidemia Clinical Trial

George Washington University - Recruiting 18 years to 80 years.
- A Case Control Study to Evaluate Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis..

Type 2 Diabetes, Coronary Artery Disease, Hypertension, or Dyslip Clinical Trial using intensive control; standard control

Kyoto University, Graduate School of Medicine - Recruiting 20 years or older.
- Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial.
intensive control; standard control

Metabolic Syndrome, Insulin Resistance, or Dyslipidemia Clinical Trial using Glucose; Fructose; High-Fructose Corn Syrup; No sugar (Aspartame)

University of California, Davis - Recruiting 18 years to 40 years.
- Effects of 2-weeks Fructose & HFCS Consumption on Dyslipidemia & Insulin Resistance.
Glucose; Fructose; High-Fructose Corn Syrup; No sugar (Aspartame)

Patients With Dyslipidemia Clinical Trial using Motivational interview

Hospital Universitario Reina Sofia - Recruiting 40 years to 75 years.
- Effectiveness of Motivational Interview in Patients With Dyslipidemia Treated in Primary Care Consultations (Dislip-EM Study).
Motivational interview

Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovas Clinical Trial using Intensive Education for Metabolic Syndrome Patients

Rajavithi Hospital - Recruiting 16 years or older.
- The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-Cohort Study).
Intensive Education for Metabolic Syndrome Patients

Diabetes, Hypertension, or Dyslipidemia Clinical Trial using MEDIC

Providence VA Medical Center - Recruiting 18 years to 85 years.
- Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes.
MEDIC

Hypertension, Insulin Resistance, or Dyslipidemia Clinical Trial using Telmisartan

Stanford University - Recruiting 10 years to 18 years.
- Randomized, Placebo Controlled, Double Blind Trial of Telmisartan in Hypertensive, Obese Adolescents.
Telmisartan